BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34762366)

  • 1. Treating melasma with the 1064 nm Nd:YAG laser with a 650-microsecond pulse duration: A clinical evaluation.
    Greywal T; Ortiz A
    J Cosmet Dermatol; 2021 Dec; 20(12):3889-3892. PubMed ID: 34762366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study.
    Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S
    Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 1064 nm Q-switched Nd:YAG laser and Jessner peeling in melasma treatment.
    Ertam Sagduyu I; Marakli O; Oraloglu G; Bulut Okut E; Unal I
    Dermatol Ther; 2022 Dec; 35(12):e15970. PubMed ID: 36346028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
    Alsaad SM; Ross EV; Mishra V; Miller L
    Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
    Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
    Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study.
    Saleh F; Moftah NH; Abdel-Azim E; Gharieb MG
    J Cosmet Dermatol; 2018 Jun; 17(3):319-327. PubMed ID: 29057567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of low-fluence 1064-nm Q-switched Nd:YAG laser with or without chemical peeling using Jessner's solution in melasma patients.
    Lee DB; Suh HS; Choi YS
    J Dermatolog Treat; 2014 Dec; 25(6):523-8. PubMed ID: 24289244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the 1064-nm Q-switched Nd:YAG laser in melasma.
    Suh KS; Sung JY; Roh HJ; Jeon YS; Kim YC; Kim ST
    J Dermatolog Treat; 2011 Aug; 22(4):233-8. PubMed ID: 20443754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of low-fluence 1,064 nm Q-Switched Nd:YAG laser with or without chemical peeling using Jessner's solution in melasma patients.
    Lee DB; Suh HS; Choi YS
    J Cosmet Laser Ther; 2014 Dec; 16(6):264-70. PubMed ID: 24245978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, split-face study comparing 1,064-nm picosecond Nd:YAG laser toning with 1,064-nm Q-switched Nd:YAG laser toning in the treatment of melasma.
    Hong JK; Shin SH; Park SJ; Seo SJ; Park KY
    J Dermatolog Treat; 2022 Aug; 33(5):2547-2553. PubMed ID: 35067157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.
    Geddes ER; Stout AB; Friedman PM
    Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A split-face study: comparison of picosecond alexandrite laser and Q-switched Nd:YAG laser in the treatment of melasma in Asians.
    Lee MC; Lin YF; Hu S; Huang YL; Chang SL; Cheng CY; Chang CS
    Lasers Med Sci; 2018 Nov; 33(8):1733-1738. PubMed ID: 29732522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel technique to treat melasma in Chinese: The combination of 2940-nm fractional Er:YAG and 1064-nm Q-switched Nd:YAG laser.
    Tian WC
    J Cosmet Laser Ther; 2016; 18(2):72-4. PubMed ID: 26836057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining Low Power Fractional CO
    Esmat S; Z Elramly A; Shahin D; Hilal RF
    Lasers Surg Med; 2021 Dec; 53(10):1325-1340. PubMed ID: 34164829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retreatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser in patients with melasma aggravation after previous therapy.
    Choi CP; Yim SM; Seo SH; Ahn HH; Kye YC; Choi JE
    J Cosmet Laser Ther; 2015 Jun; 17(3):129-34. PubMed ID: 25415369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual Toning Method with the Combination of Picosecond and Microsecond Nd:YAG in Refractory Melasma Unresponsive to Picosecond Alone.
    Hai L; Phuong B; Ha L; Lam V; Van B; Al-Niaimi F
    J Cutan Aesthet Surg; 2021; 14(1):101-106. PubMed ID: 34084016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-power fractional CO₂ laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study.
    Jalaly NY; Valizadeh N; Barikbin B; Yousefi M
    Am J Clin Dermatol; 2014 Aug; 15(4):357-63. PubMed ID: 24858737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?
    Gokalp H; Akkaya AD; Oram Y
    J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
    Ustuner P; Balevi A; Ozdemir M
    J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Topical Silymarin Versus Low Fluence 1064-nm Q Switched Nd:YAG Laser in the Treatment of Melasma: A Comparative Randomized Trial.
    Ibrahim SMA; Farag AS; Ali MS; El-Gendy WMAF
    Lasers Surg Med; 2021 Dec; 53(10):1341-1347. PubMed ID: 34101206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.